Trials / Sponsors / Arvinas Inc.
Arvinas Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation KRAS G12D Mutation, Advanced Solid Cancer | Phase 1 / Phase 2 | 2025-05-29 |
| Recruiting | A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL), Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) | Phase 1 | 2024-09-05 |
| Completed | A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery Breast Cancer | Phase 2 | 2023-02-15 |
| Completed | Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer Prostate Cancer Metastatic | Phase 1 / Phase 2 | 2019-03-01 |